Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 162

The DOI matches its Crossref record.

Ketoconazole vs. Itraconazole for Antifungal Prophylaxis in Patients with Severe Granulocytopenia: Preliminary Results of Two Nonrandomized Studies

Thicot, G., Joosten, E., Boogaerts, M. A., Vande Pitte, J., Cauwenbergh, G.·1987·Clinical Infectious Diseases

Abstract

The efficacies of antifungal prophylaxis with ketoconazole and itraconazole, a new triazole, in patients with prolonged granulocytopenia were evaluated in two nonrandomized studies. The conditions other than the drug administered for prophylaxis were equivalent in the two studies. The incidence of fatal fungal infections was significantly higher among patients given ketoconazole than among those given itraconazole (P = .02); this trend was especially evident with fatal infections due to Aspergillus (P = .0045). The level of protection from fatal fungal infection afforded by itraconazole was highly significant among patients who were granulocytopenic for more than 25 days (P less than .0001) and among patients with acute lymphoblastic leukemia (P = .008). Failures of prophylaxis with itraconazole may have been due to inadequate levels of drug in plasma. Although these results must be interpreted with caution because they were obtained in consecutive nonrandomized studies, the use of itraconazole for antifungal prophylaxis in granulocytopenic patients seems to be a major advance and to be especially advantageous in hospitals, where the incidence of fatal aspergillosis in these patients is high.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/clinids/9.supplement_1.s94

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 162

Metadata

Authors
Thicot, G., Joosten, E., Boogaerts, M. A., Vande Pitte, J., & Cauwenbergh, G.
Venue
Clinical Infectious Diseases
Published
1987-01-01
Volume
9
Issue
Supplement_1
Pages
S94-S99
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W1978519737
Cited by
162
References
0
FWCI
9.32
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ketoconazole vs. Itraconazole for Antifungal Prophylaxis in Patients with Severe Granulocytopenia: Preliminary Results of Two Nonrandomized Studies. https://app.cochat.ai/papers/10.1093/clinids/9.supplement_1.s94
The paper
Thicot, G., Joosten, E., Boogaerts, M. A., Vande Pitte, J., & Cauwenbergh, G. (1987). Ketoconazole vs. Itraconazole for Antifungal Prophylaxis in Patients with Severe Granulocytopenia: Preliminary Results of Two Nonrandomized Studies. Clinical Infectious Diseases. https://doi.org/10.1093/clinids/9.supplement_1.s94

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.